GILD

Gilead Sciences, Inc. News Headlines

$103.84
*  
0.92
0.88%
Get GILD Alerts
*Delayed - data as of Sep. 17, 2014  -  Find a broker to begin trading GILD now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    GILD Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Forecasting Earnings Growth And Profitability In The Biopharmaceutical Industry
1/21/2014 7:19:00 AM - Seeking Alpha

Growth Portfolio Semi-Finals: General Motors Vs. Gilead
1/21/2014 12:28:00 AM - Seeking Alpha

Gilead Is Not Done; There Is Potentially 50% More Upside This Year
1/17/2014 5:32:00 PM - Seeking Alpha

ModernGraham Valuation Of Gilead Sciences
1/17/2014 3:06:00 PM - Seeking Alpha

All Signs Point To Geron's Imetelstat Being The Holy Grail Of Myeloproliferative Drugs
1/17/2014 2:37:00 PM - Seeking Alpha

Stocks 2014: Investing For Growth - The Power And Protection Of High Compounding Earnings Growth - Part 2
1/16/2014 2:14:00 PM - Seeking Alpha

Stocks 2014: Investing For Growth - The Power And Protection Of High Compounding Earnings Growth - Part 2
1/16/2014 1:19:00 PM - Seeking Alpha

The Short Story Of Intercept Pharmaceuticals (Part I): A Conference Call With Expert Physicians
1/14/2014 10:20:00 AM - Seeking Alpha

Cramer's Lightning Round - I Can't Get My Arms Around The New Kodak (1/10/14)
1/12/2014 6:29:00 AM - Seeking Alpha

Cramer's Mad Money - 11 Earnings To Watch In The Week Ahead (1/10/14)
1/12/2014 6:26:00 AM - Seeking Alpha

The Gilead Rebuttal
1/6/2014 8:38:00 AM - Seeking Alpha

Positioning For 2014 In The Health Care Sector
1/6/2014 8:04:00 AM - Seeking Alpha

Pharmacyclics: As Imbruvica Commercialization Begins, Sell-Off Creates Opportunity
1/3/2014 10:12:00 AM - Seeking Alpha

Gilead Seeks To Expand Its Blockbuster Hepatitis Platforms In 2014
1/3/2014 2:27:00 AM - Seeking Alpha

Growth Portfolio Super Bowl
12/31/2013 2:03:00 AM - Seeking Alpha

Should You Sell Gilead Sciences After A Successful 2013?
12/30/2013 1:00:00 PM - Seeking Alpha

Gilead Sciences And The Numbers Game
12/23/2013 9:51:00 AM - Seeking Alpha

2 Big Biotechs Moving Up On News
12/20/2013 12:10:00 PM - Seeking Alpha

Cramer's Mad Money - Themes That Will Work For 2014 (12/19/13)
12/20/2013 6:23:00 AM - Seeking Alpha

Hep C Price War? Abbvie Vs. Gilead
12/16/2013 6:08:00 AM - Seeking Alpha

Ziopharm: Finally A Winner In The War On Cancer?
12/15/2013 1:22:00 PM - Seeking Alpha

Don't Short Gilead Sciences Just Yet
12/13/2013 11:08:00 AM - Seeking Alpha

Lessons Learned From The Top 20 Stocks Of 2013
12/11/2013 4:44:00 PM - Seeking Alpha

Invest In Gilead Sciences For Long-Term Hepatitis C Franchise
11/4/2013 2:13:00 AM - Seeking Alpha

Gilead Sciences - After Another Amazing Year, It Is Time To Be Cautious
11/1/2013 5:29:00 AM - Seeking Alpha